Integer Holdings (ITGR) Reaches $43.50 52-Week High, Radius Health (RDUS) Has 0.84 Sentiment

July 17, 2017 - By Nellie Frank

The stock of Integer Holdings Corporation (NYSE:ITGR) hit a new 52-week high and has $45.68 target or 5.00% above today’s $43.50 share price. The 9 months bullish chart indicates low risk for the $1.36 billion company. The 1-year high was reported on Jul, 17 by Barchart.com. If the $45.68 price target is reached, the company will be worth $68.00M more. About 32,831 shares traded. Integer Holdings Corporation (NYSE:ITGR) has risen 24.88% since July 17, 2016 and is uptrending. It has outperformed by 8.18% the S&P500.

Radius Health, Inc. is a biopharmaceutical company. The company has market cap of $1.87 billion. The Firm is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. It currently has negative earnings. The Company’s lead investigational product candidate, abaloparatide for subcutaneous injection, or abaloparatide-SC, has completed Phase III development for potential use in the treatment of women with postmenopausal osteoporosis.

About 1.43 million shares traded or 62.39% up from the average. Radius Health Inc (RDUS) has risen 9.02% since July 17, 2016 and is uptrending. It has underperformed by 7.68% the S&P500.

Since January 1, 0001, it had 13 buys, and 0 sales for $24.32 million activity.

Analysts await Radius Health Inc (NASDAQ:RDUS) to report earnings on August, 3 after the close. They expect $-1.35 earnings per share, down 33.66% or $0.34 from last year’s $-1.01 per share. After $-1.32 actual earnings per share reported by Radius Health Inc for the previous quarter, Wall Street now forecasts 2.27% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.